Comparison of Self-reported Cognitive Difficulties in a National Sample of Long-Term Cancer Survivors and Cancer-Naive Controls

Psychosomatics

Volumn 53, Issue 1, 2012, Pages 68-74

  Braun, Ilana M ^a   Rao, Sowmya R ^b,d   Pirl, William F ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^d Outcomes and Economic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVOR; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM SURVIVAL; MALE; MELANOMA; MEMORY; MENTAL CONCENTRATION; OVARY CANCER; PROSTATE CANCER; SELF REPORT; THINKING; UNITED STATES; UTERINE CERVIX CANCER; UTERUS CANCER; ATTITUDE TO HEALTH; COMORBIDITY; EPIDEMIOLOGY; MEMORY DISORDER; MENTAL DISEASE; MIDDLE AGED; NEOPLASM; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; SELF EVALUATION; SOCIOECONOMICS; STATISTICS; SURVIVOR;

ANTINEOPLASTIC AGENT;

ADULT; ANTINEOPLASTIC AGENTS; ATTITUDE TO HEALTH; COGNITION DISORDERS; COMORBIDITY; DIAGNOSTIC SELF EVALUATION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MEMORY DISORDERS; MENTAL DISORDERS; MIDDLE AGED; NEOPLASMS; SOCIOECONOMIC FACTORS; SURVIVORS; UNITED STATES;

EID: 84859536168     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2011.07.010     Document Type: Article

References (18)

1. Edwards B.K., Brown M.L., Wingo P.A. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Institute 2005, 97:1407-1427.
2. Mar Fan H.G., Houede-Tchen N., Yi Q.L. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005, 23:8025-8032.
3. Tchen N., Juffs H.G., Downie F.P., et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003, 21:4175-4183.
4. Vardy J., Wefel J.S., Ahles T., et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008, 19:623-629.
5. Ahles T.A., Saykin A.J., Furstenberg C.T., et al. Neuropsychological impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002, 20:485-493.
6. Wieneke M.H., Dienst E.R. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 1995, 4:61-66.
7. Silverman D.H., Dy C., Castellon S.A., et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 2007, (103):303-311.
8. Schagen S.B., van Dam F.S., Muller M.J., et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999, 85:640-650.
9. Keating N.L., Norredam M., Landrum M.B. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 2005, 53:2145-2152.
10. Hurria A., Somlo G., Ahles T. Renaming "chemobrain.". Cancer Invest 2007, 25:373-377.
11. Hoffman K.E., McCarthy E.P., Recklitis C.J., et al. Psychological distress in long-term survivors of adult-onset cancer. Arch Intern Med 2009, 169:1274-1281.
12. Kessler R.C., Berglund P., Chiu W.T., et al. The US National Comorbidity Survey Replication (NCS-R): Design and field procedures. Int J Methods Psych Research 2004, 13:69-92.
13. Greer J.A., Solis J.M., Temel J.S., et al. Anxiety disorders in long-term survivors of adult cancers. Psychosomatics 2011, 52:417-423.
14. Pirl W.F., Greer J., Temel J.S., et al. Major depressive disorder in long-term cancer survivors: analysis of the National Comorbidity Survey Replication. J Clin Oncol 2009, 27:4130-4134.
15. Kessler R.C., Berglund P., Demler O., et al. National Comorbidity Survey Replication: the epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
16. Ustun T.B., Chatterji S., Kostanjsek N., et al. WHO/NIH Joint Project. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Org 2010, 88:815-823.
17. Jenkins V., Shilling V., Deutsch G., et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J of Cancer 2006, 94:828-834.
18. Mehnert A., Scherwath A., Schirmer L., et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue, and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 2007, 66:108-118.